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Epidermal I -J-Bearing Cells Are Responsible for Transferable 
Suppressor Cell Generation After Immunization of Mice with Ultraviolet 
Radiation-Treated Epidermal Cells 
RICHARD D. GRANSTEIN, M.D. 
Department of Dermatology, Harvard Medical School and Ma.~.mchusetts General Hospital, Boston, Massachusetts, U.S.A. 
Subcutaneous immunization of mice with hapten-cou-
pled, ultraviolet radiation (UVR)-treated epidermal 
cells (EC) results in a hyporesponsive delayed-type hy-
persensitivity (DTH) response associated with the ap-
pearance of afferent-acting, hapten-specific T suppres-
sor (Ts) cells. Depletion of 1-J-bearing cells from the EC 
population prior to UVR-exposure and hapten coupling 
prevents the appearance of these Ts cells. However, non-
UVR-treated EC depleted of 1-J-bearing cells and hap-
ten-coupled are capable of immunizing mice for a DTH 
response. Therefore, the set of 1-J-bearing EC appears 
to be distinct from classic Langerhans cells. A novel set 
of 1-J-bearing EC appears to be responsible forTs acti-
vation after subcutaneous immunization with hapten-
coupled UVR-treated EC. 
In the azobenzenearsonate (ABA) hapten system the i.v. 
administration of ABA-coupled spleen cells into syngeneic mice 
results in the appearance of potent, afferent-acting T suppres-
sor cells, termed first-order suppressor cells (Tsl), in the thy-
mus, sp leen, and lymph nodes (1]. Tsl cells bear idiotopes 
recognized by rabbit anti-idiotypic antibody and produce a 
ligand-specific, 1-J-bearing soluble factor termed first-order 
suppressor factor (TsF 1) that functions to activate second-order 
suppressor cells (Ts2). Ts2 cells bear anti-idiotypic receptors 
and differ functionally from Tsl cells by being able to suppress 
not only in the afferent phase of an immune response, but also 
in the efferent phase, that is, they are capable of suppressing 
an ongoing immune response. Ts2 cells, in turn, produce a 
soluble factor that bears anti-idiotypic receptors and an 1-J 
determinant, called second-order suppressor factor (TsF2). 
TsF 2 functions as one signal necessary for the activation of 
idiotope-bearing third-order suppressor cells (Ts3, also called 
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Abbreviations: 
ABA: azobenzenearsonate 
APC: ant igen-presenting cell 
C: complement 
CAFt: (BALB/c X A/J)Ft (m ice) 
CHS: contact hypersensit ivity 
DTH: delayed-type hypersensitivity 
EC: epidermal cell(s) 
HBSS: Hanks' balanced salt solution 
LC: Langerhans cell(s) 
PBS: phosphate-buffered saline 
Th: helper cell(s) 
Ts: suppressor cell (s) 
Tsl, Ts2, Ts3: first-order T s, second-order Ts, etc. 
TsFt. TsF2: first-order suppressor factor, etc. 
SC: spleen cell(s) 
TNCB: trin itrochlorobenzene 
TNP: trinitrophenyl 
UVR: ultraviolet radiation 
effector-suppressor cells). The activation of Ts3 cells requires 
a second signal consisting of ligand bound to a special I-J-
bearing, antigen-presenting cell (APC) [1,2]. Once activated, 
Ts3 cells serve to suppress both the afferent and efferent limbs 
of an immune response in an antigenically nonspecific manner. 
We have recently described a special ultraviolet radiation 
(UVR)-resistant epidermal APC capable of suppression of a 
delayed-type hypersensitivity (DTH) response in concert with 
TsF 2 administration, and thus presumably involved in the 
activation of Ts3 cells [3] . 
We now report that I-J-bearing epidermal cells (EC) are 
responsible for the activation of afferent acting, antigen -spe-
cific, transferable, T suppressor cells after immunization of 
mice with ABA-coupled, UVR-treated EC. 
MATERIALS AND METHODS 
Mice 
Female (BALB/c X A/J)F, (CAF 1) (1-Jdfk) mice were purchased from 
the Jackson Laboratory, Bar Harbor, Maine. All mice were 6- 8 weeks 
of age at the t ime of use, and were maintained at the vivarium at 
Harvard Medical School or the Massachusetts General Hospital. 
Preparation of EC 
EC were prepared by modification of a previously described tech· 
nique [4) . The dorsal surface of mice was shaved with electric clippers 
(Oster, Milwaukee, Wisconsin) and then chemically depilated (Neet, 
Whitehall Laboratories, New York, New York). After sacrifice, the 
dorsal skin was excised, subcutaneous tissue was mechanically re.-
moved, and the skin was floated, dermis side down, on 1% trypsin in 
phosphate-buffered saline (PBS) for 45 min at 37"C. Epidermal sheets 
were then mechanically removed from the skin, washed twice in Hanks' 
balanced salt solution (HBSS), minced, and stirred in RPMJ media 
containing 10% fetal calf serum (10% RPMI) for 1 h at 4 ·c with a 
magnetic stirrer. Then, 0.05 % DNase (Type I, Sigma, St. Louis, Mis-
souri) in 10% RPMI was added to the mixture for a final concentration 
of 0.025%. An additional 20 min of stirring was performed and the 
mixture was filtered through nylon mesh (Nytex, Tetko, Elmsford, 
New York) . The filtrate was vigorously pipetted to break up clumps 
and washed 3 times in HBSS to yie ld a monocellular suspension of EC. 
Spleen Cell (SC) Preparation 
Mice were sacrificed and spleens harvested. The spleens were then 
mechanically disrupted to yield a monocellular suspension. In all trans-
fer studies, 5 X 107 viable nucleated splenocytes were administered i.v. 
to each recipient. For immunization, red blood cells were lysed with 
0.83% NH.Cl in Tris buffer prior to ABA coupling. 
Immunization of Mice 
Mice were immunized by injection with 5 x 106 ABA-coupled EC or 
3 x 107 nucleated SC s.c. as described previously [5). ABA coupling 
was as described [5). Immunization to trinitrophenyl (TNP) was per-
formed by s.c. injection of 5 x 106 TNP-coupled EC or 1 x 107 TNP-
coupled SC. TNP coupling was performed by incubating cells in 10 mM 
trinitrobenzenesulfonic acid (Sigma) , for 10 min at 37"C followed by 
extensive washing of cells. 
Delayed-Type Hypersensitivity Assay for ABA 
206 
The DTH assay has been described [5] . Briefly, mice were challenged 
in the left hind foot pad 5 days after immunization with 30 1'1 of 10 
mM active ABA solution. Twenty-four hours later, foot pad swelling 
March 1985 1-J-BEARING EPIDERMAL CELLS IN SUPPRESSOR CELL GENERATION 207 
was assessed by measuring both foot pads and subtracting the right 
foot pad thickness from that of the left. 
Contact Hypersensitivity (CHS) Assay for TNP 
Five microliters of 1% trinitrochlorobenzene (TNCB) in acetone was 
painted on each side of each ear and 24-h swelling was assessed. 
UVR Treatment of EC 
Three milliliters of PBS containing 107 EC/ml were plated in each 
of several 100 rum-diameter Petri dishes (Costar, Cambridge, Massa-
chusetts) and were exposed to 0.66 kJ / m2 of UVR from a bank of FS-
40 sunlamps (Westinghouse, Bloomfield, New Jersey) , measured by an 
IL-443 radiometer equipped with an SEE-1240 detector and W#l078 
and CF94 7R filters (International Light, Newburyport, Massachu -
setts). The characteristics of this UVR source have been described 
[6]. After irradiation, EC were washed twice with HBSS. 
Antibody and Complement (C) Treatment 
Monoclonal anti-J-Jk antibody (WF8.C.12.8) a nd monoclonal anti-
I-J" (WF9.1.4) from supernatant were the generous gifts of Dr. Carl 
Waltenbaugh, Northwestern University. These antibodies were puri-
fied on protein A columns. To delete EC expressing I-J, cells were 
incubated in HBSS containing 2% fetal calf serum (2 % HBSS) and 2 
~tg/ml of a ntibody at a concentration of 107 cells/ ml for 15 min on ice 
followed by 15 min at 3TC. Then, the cells were sedimented before 
resuspension in 2% HBSS containing a 1:20 dilution of rabbit C (Pel-
Freeze Biologicals, Rogers, Arkansas) at a concentration of 107 cells/ 
ml and incubation at 37•c for 45 min. The cells were then washed 
extensively in HBSS. The specificity of the same batch of anti-J-Jk 
monoclonal antibody was established independently in experiments 
with anti-1-J-mediated modulation of tumor growth (7]. Deletion ofT 
cells was performed in an identical manner using monoclonal anti-Thy 
1.2 (HO 13.4). 
In Vitro Generation of Cytolytic Effector Cells 
Spleen cells (7 X 106 ) from mice primed in vivo with ABA-coupled 
syngeneic EC were cultured in 5% C02 at 37·c in 16-mm Costar tissue-
culture wells with 6 x 106 gamma-irradiated (1500 rads) ABA-coupled 
spleen cells for 5 days. The ABA-coupling procedure is the same as 
that described for in vivo immunization. The medium used for gener-
ation of killer cells was RPMI 1640 supplemented with penicillin G 
(100 U/ml), streptomycin (100 !Lg ml), L-glutamine (2 mM) , sodium 
pyruvate (1 mM), nonessential amino ac ids (0.1 mM of each amino 
acid), 2-mercaptoethanol (2-Me) (5 X 10-" M), and 10% heat-inacti -
vated fetal calf serum. 
"Cr-Release Assay 
Cytolytic activity was assessed by incubating effector cells with "'Cr-
labeled concanavalin A-induced blasts for 4 h. Targets (1 X 104 in 0.1 
ml 5% fetal calf serum-minimal essential medium supplemented with 
nonessential amino acids) were mixed with 0.1 ml of effector cells to 
give fin al effector:target cell ratios of 100:1, 33:1, and 11:1. The suspen -
sions were spun at 300 gat 4•c for 30 s before incubation at 37•c in 
5% C02• Both uncoupled and ABA-coupled targets were used to detect 
the hapten-specific killing. Specific release of "'Cr was calculated for 
the equation E-S/M-S, where E is the isotope release in wells con-
taining immune effectors plus targets, S is the spontaneous isotope 
release in wells containing only targets, and M is the maximum isotope 
release obtained by solubilizing targets with 3-fold diluted Triton X-
100. All measurements were performed in duplicate. The difference 
between duplicate wells was under 5%. 
Statistics 
Comparisons were done with the Student's t-test. 
RESULTS 
Immunization of Mice with UVR-Treated EC Results in the 
Appearance of Antigen-Specific Splenic Suppressor Cells 
Unless 1-J-Bearing Cells Are Deleted from the Immunizing 
Population of EC 
Table I demonstrates in 2 experiments that immunization of 
mice with ABA-coupled, UVR-treated EC results in a signifi-
cantly decreased DTH response (group 2) compared to hapten-
coupled, nonirradiated EC. Furthermore, depletion of 1-J-bear-
ing cells with monoclonal anti-1-Jk antibody and C treatment 
does not impair the ability of nonirradiated EC to immunize 
(group 3) these animals, or of UVR-treatment of these cells to 
yield a depressed response on immunization (group 4). Groups 
5 and 6 show the same results when EC are treated with anti-
1-J" monoclonal antibody and C. 
Table II demonstrates, similarly, that immunization of mice 
with TNP-coupled, UVR-treated EC also results in significant 
hyporesponsiveness, as demonstrated previously (8]. We then 
evaluated whether immunization with ABA-coupled, UVR-
treated EC results in the appearance of suppressor cells capable 
of down-regulating the afferent arm of the immune response. 
In these experiments mice in each of the groups shown in Table 
I, Exp 1, were sacrificed and splenocytes from each group were 
transferred i.v. into naive recipients (5 X 107 viable nucleated 
cells per mouse) . One hour later, recipients were immunized 
s.c ., and the mice were subsequently challenged on day 5. Table 
III shows that donors immunized with ABA-coupled, UVR-
treated EC demonstrate significant suppressor cell activity on 
adoptive transfer (group 2). However, donors immunized with 
TABLE II. CHS responses after immunization with TNP-coupled, 
UVR-treated EC 
Group• uvR• DTH ± SEM (mm X 1.0-2 ) ' 
1 23.8 ± 1.3 
p Value• 
2 + 14.6 ± 1.6 0.004 
3 Negative control 6.6 ± 1.1 
"N = four in all groups; group 3 not immunized (negative control). 
b EC were exposed in vitro to 0.66 kJ/m2 of UVR prior to TNP 
coupling. 
' CAF, mice were challenged on both ears with 5 ~tl of 1% TNCB in 
acetone applied to each side of each ear and 24-h swelling was assessed. 
• Group 2 compared with group 1; Student's t-test. 
TABLE I. DTH responses after immunization with ABA-cou.pled, UVR-treated EC and l-J-bearill{J cell-depleted EC 
Group" 
1 
2 
3 
4 
5 
6 
7 
" N = four in all groups. 
Treatment 
ofEC 
c 
c 
Anti-J-Jk + C 
Anti-J-Jk + C 
Anti -1-J" + C 
Anti-I-J" + C 
No immunization 
(negative control) 
Exp I 
uvR• DTH ±SEM 
(mm x 10-'y 
32.0 ± 3.7 
+ 13.6 ± 1.6 
33.8 ± 2.1 
+ 10.8 ± 1.3 
36.5 ± 4.3 
+ 16.0 ± 2.1 
11.5 ± 2.1 
b EC were exposed in vitro to 0.66 kJ/ m2 of UVR prior to ABA coupling. 
Exp 2 
p Value" DTH ± SEM (mm x 10-2)' 
28.8 ± 3.9 
0.004 13.8 ± 0.9 
29.8 ± 3.9 
0.0001 13.8 ± 0.9 
NT' 
0.005 NT' 
12.0 ± 2.3 
c CAF 1 mice were challenged in the left hind foot pad with 30 ~tl of 10 mM ABA solution 5 days after immunization. 
d Group 2 compared to group 1, group 4 compared to group 3, and group 6 compared to group 5; Student's t-test. 
• NT = Not tested. 
p Value" 
0.010 
0.010 
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ABA-coupled, UVR-treated EC dep leted of I-J bearing cells do 
not demonstrate significant suppressor cell activity (group 4). 
This occurs despite the finding that hyporesponsiveness is 
found after immunization with ABA-coupled, UVR-treated EC 
populations depleted of 1-J-bearing cells (Table I). In one 
additional experiment (data not shown), treatment of EC with 
TABLE Ill. Inhibit ion of the induction of ABA -specific DTH by SC 
from. immunized mice 
sc DTH ± SEM p Group" Donor immunization transferred'' (mm x 10-2)' Valuesd 
1 ABA -coupled, C-treated EC + 40.3 ± 2.5 
2 ABA -coupled, UVR-trea ted , C- + 27 .8 ± 3.1 0.020 
treated EC 
3 ABA -coupled, ant.i-1-Jk + C- + 41.3 ± 2.3 
treated EC 
4 A SA-coupled , anti-1-,Jk + C- + 35.5 ± 2.0 0.106 
treated, UVR-treated EC 
5 A SA-coupled, a nti -1-.J" + C- + 43. 3 ± 3.1 
treated EC 
6 ABA -coupled, anti-I-J" + C- + 24.3 ± 1.5 0.001 
treated, UVR-treated EC 
7 No immunization + 41.5± 1.7 
8 TNP-coupled, UVR-treated EC + 42.3 ± 2.4 0.795 
9 10.3 ± 2.8 
"N = four in a ll groups. 
b Viable nucleated SC (5 x 107 ) we re transferred from donors as 
shown (from groups in Table I, Exp 1) i.v. into naive recipients. 
Recipients were immunized with 3 X l 07 ABA-coupled naive SC 1 h 
after SC t ransfer. 
'CAF, mice were challenged as in Table I. 
"G roup 2 compared with group 1, group 4 with group 3, group 6 with 
group 5, group 8 with group 7; Student's t-test. 
TABLE IV . Inhibition of the induction of TNP-specific CHS by SC 
from. immunized mice 
Group" Donor immunization sc DTH ±SEM p Values" transferred• (mm x 10- 2)' 
1 TNP-coupled EC + 11.8 ± 0.3 
2 TNP-coupled, + 7.5 ± 0.2 <0.001 
UVR-treated EC 
3 No immunization + 11.6 ± 0.8 
4 ABA-coupled, UVR- + 12.3 ± 0.7 0.535 
treated, C-treated 
EC 
5 6.5 ± 0.7 
"N = four in a ll groups. 
1
' Viable nucleated SC (5 x 107 ) were transferred from donors as 
shown (from !,'TOups in Table I, Exp 1 and Table II) i.v. into naive 
recipients. Recipients were immunized with 1 X 107 TNP-coupled naive 
SC 4 h after SC transfer. 
' CAF , mice were challenged as in Table II. 
"Group 2 compared to group 1, group 4 compared to group 3; 
Student's t-test. 
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complement prior to washing and anti-1-Jk antibody treatment 
failed to eliminate suppressor cell formation when these cells 
were UVR-treated and used for immunization. The specificity 
of the antibody is demonstrated by group 6; treatment of EC 
with monoclonal anti-1-J" antibody and complement prior to 
UVR treatment and ABA-coupling does not prevent induction 
of suppressor cell activity after immunization. Group 8 dem-
onstrates the specificity of the induced suppressor cells by 
showing that SC from mice immunized with TNP-coupled, 
UVR-treated EC do not suppress the ABA response. Table IV 
shows that this SC population does indeed contain TNP-
specific suppressor activity (group 2) and that ABA-specific 
suppressor cells do not suppress the TNP response (group 4). 
Thus, suppressor cells induced by immunization with ABA-
coupled, UVR-treated EC are antigen-specific. 
Spleen cells from each group in Table I, Exp 2, were trans-
ferred to naive recipients that were immunized with ABA-
coupled spleen cells lh later. Five days later SC from these 
recipients were used as effector cells in a cytotoxic lymphocyte 
(CTL) assay after restimulation in vitro. Table V demonstrates 
that suppressor cells induced by immunization with hapten-
coupled UVR-treated EC also suppress CTL activity (group 5). 
The other groups shown in Table V confirm that depletion of 
1-J-bearing cells from the immunizing EC population prevents 
suppressor cell induction. 
Suppressor Cells Induced by Immunization with ABA-Coupled, 
UVR-Treated EC Do Not Function in the Efferent Limb of the 
Immune Response, and Are T Lymphocytes 
Table VI demonstrates that this same population of suppres-
sor cells is unable to suppress the immune response in previ-
ously immunized mice. In this experiment, animals received 5 
X 107 viable nucleated cells 5 days after immunization and 2 h 
prior to challenge. Thus, the suppressor cells induced appear 
to act only afferently. 
TABLE VI. Effect of Ts cells on the elicitation response of ABA 
immune mice 
sc Recipients DTH ±SEM Group" transferred" sens iti zed (mm X 10-")' p Value" to ABA 
1 + + 36.3 ± 4.0 
2 + 35.8 ± 6.4 0.949 
3 13.8 ± 1.7 0.001 
" N = 4 in all groups. 
b 5 X 107 SC transferred to immune recipients 5 days after immuni-
zation and shortly before challenge (performed as in Table I). SC were 
shown to suppress the induction of immunity to ABA in a separate 
experiment (not shown). 
' CAF, mice were challenged as in Table I. 
"Compared to group 1, Student's t-test. 
TABLE V. Inhibition of the induction of cytotoxic precursor cells by SC from. immunized mice 
sc Percent lysis• Group Donor immunization transferred" ABA·CAF, Uncoupled CAF, 
100:1 33:1 11:1 100:1 33:1 11:1 
1 No Immunization + 56.6 44.9 48.6 12.5 14.5 16.4 
2 ABA-coupled, anti -J.Jk + + 56.9 49.9 43.6 14.3 12.5 12.5 
C-treated EC 
3 ABA-coupled, UVR-treated + 53.6 46.8 45.8 12.0 11.6 8.6 
anti-J-Jk + C-treated EC 
4 ABA-coupled, C-treated EC + 58.4 52.3 40.2 16.6 13.8 4.5 
5 ABA-coupled, UVR- + 32.4 30.2 23.3 12.6 7.3 5.9 
treated, C-treated EC 
6 0 0 0 0 0 0 
"Viab le nucleated SC (5 X 107 ) were transferred from donors as shown (from groups in Table I, Exp 2) i.v. into naive recipients. Recipients 
were immunized with 3 x 107 ABA-coupled naive SC 1 h after SC transfer. 
"SC from each group were cultured in vitro for 5 days with gamma-irradiated ABA-coupled syngeneic SC to generate cytolytic effector cells. 
Effectors were assayed on "'Cr-labe led concanavalin A blasts. Spontaneous release of "'Cr ranged from 31- 33%. 
March 1985 I-J-BEARING EPIDERMAL CELLS IN SUPPRESSOR CELL GENERATION 209 
TABLE VII. T s cells are T ly mphocytes 
'T' reatment Recipients 
Group" Donor ofSC immu - DTH ± SEM p immunization transferred' nized (mm X 10- ') ' Yaluesd to ABA 
Not immunized + 38.5 ± 2.2 
2 ABA-coupled, c + 18.0 ± 2.9 0.001 
UVR-treated, 
EC 
3 ABA -coupled, Anti-Thy + 35.3 ± 2.9 0.413 
UVR-treated 1.2 + c 
EC 
4 No donors No transfer 10.3 ± l.O <0.001 
"N =four in all groups. 
• Viable nucleated SC (5 x 107) t ransferred i.v. after t reatment, as 
shown. 
' CAF, mice were challenged as in Table I. 
d Compared to group 1; Student's t-test. 
T able VII demonstrates that these suppressor cells are T 
lymphocytes. SC obtained from donors immunized with ABA-
coupled, UVR-treated EC and t reated with C prior to t ransfer 
to naive recipients (group 2) suppress the induction of ABA-
specific immunity in t he recipients. However, t reatment of 
t hese SC with ant i-Thy 1.2 antibody and C completely elimi-
nates suppressive activity (group 3). Thus these cells are T 
suppressor cells (Ts). 
DISCUSSION 
It has been previously demonstrated in t he TNP hapten 
system t hat immunization of mice with hapten-coupled, UVR-
treated EC results in a decreased DTH response accompanied 
by transferable T suppressor cells [8]. This report demonstrates 
that t hese suppressor cells appear to arise as a consequence of 
t he presence of a novel 1-J-bearing cell in t he epiderm is of 
mice. This cell appears to be distinct from classic Langerhans 
cells (LC) since depletion of 1-J-bearing cells fro m EC popu la-
t ions does not prevent positive immunization for a DTH re-
sponse. However, it is possible that this cell represen ts a subset 
of LC or Langerhans-like cells. The suppressor cells induced 
are afferent acti ng only, are hapten-specific, and are T lympho-
cytes. Thus, they appear to be Tsl cells in the context of the 
ABA hapten system. As mentioned above, we have previously 
described an 1-J-bearing epidermal APC capable of activating 
Ts3 cells in concert with TsF2 (3]. We do not yet know whether 
t hese 2 functions , activation of T sl and T s3 cells, are subserved 
by identical 1-J-bearing EC, or whether 2 sets of I-J -bearing 
EC are involved. 
The finding t hat immunization with UVR-treated EC results 
in suppressor cell (Ts) formation upon s.c. inoculation appears 
to contradict our previous report that simultaneous immuni-
zation with ABA-coupled, UVR-treated EC and ABA-coupled 
naive SC results in a posit ive response unless TsF2 is admin-
istered [3]. This may be expla ined by postulating that immunity 
is dominant to suppression upon t his type of simultaneous 
immunization. After UVR treatment of immunizing cell popu-
lations, !-A-bearing antigen-presenting cell function appears to 
be compromised, leading to dominant stimulation of T s activity 
by certain 1-J-bearing EC. 
The observation that a set of specia l UVR-resistant EC exists 
t hat is active in t he generation of various elements in the 
suppressor cell cascade is of great significance in understanding 
t he immunology of t he skin. As we have previously speculated 
(3], such cells may account fo r t he finding that percutaneous 
immunization with a hapten at a UVR-treated site in vivo 
results in suppressor cell formation in mice (9]. It is possible 
t hat the 1-J-bearing EC "presents '' the hapten preferentially 
for Ts generation at UVR-treated sites because UVR has ab-
rogated t he ability of t he epidermis at that site to present 
hapten for helper cell (Th) generation. These novel 1-J-bearing 
APC may a lso be involved in t he induction of UVR-induced 
skin tumors. In t he murine UV -radiated tumor system, t he 
development and growth of UVR-induced skin t umors has been 
shown to be influenced by t he appearance of Ts that recognize 
most syngeneic UVR-induced skin tumors [10-12]. These cells 
appear in t he course of UVR treatment even before the overt 
appearance of tumors. If UVR causes the expression of UVR-
tumor associated ant igens as well as inactivating !-A-bearing 
APC, t hen 1-J-bearing, UVR-resistant APC may function to 
present certain of t hese tumor-associated antigens for suppres-
sor cell activation . 
The finding that 1-J-bearing EC function in t he activation 
of afferent suppressor cells after UVR treatment en larges t he 
role of 1-J -bearing EC in cutaneous antigen presentation. As a 
composite, the functions of the set of I-J-bearing EC in t he 
activation of suppressor cells may be analogous to the role of 
the !-A-bearing LC in the activation of immunity in t he skin . 
Thus, t he set of I-J -bearing EC appears to be a crucial element 
involved in determining t he balance of immunologic response 
and nonresponse in t he skin . The recent observation (S. Sulli -
van, personal communication) t hat purified populations of t he 
newly described Thy-\ antigen-bearing EC [13,14] down-regu-
late immunity when hapten-coupled and given i.v. suggests t he 
possibility t hat the set of Thy-! antigen-bearing EC overlaps or 
is identical to the set of 1-J-bearing EC. 
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